Stemline Therapeutics, Inc.

Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Home

	The Company
	Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing oncology compounds directed towards cancer stem cell targets.

	Platform
	Stemline Therapeutics has developed a Discovery Platform called "StemScreen^®" to identify novel compounds that target and kill CSCs.

News
&
Events

12/4/2009
Stemline announces presentation of SL-401 and SL-501 activity in CML at ASH

11/30/2009
Stemline Expands Clinical Oncology Program With Addition of M.D. Anderson

7/30/2009
Stemline CEO is invited speaker at New Frontiers in Cancer Drug Development